ArisGlobal Recognized as a Major Contender in Everest Group’s “Clinical Development Platform Vendors” PEAK Matrix® Assessment 2020

Nov 19, 2020

Innovation, digitally mature products drive company growth, report says


ArisGlobal, the leading provider of software that automates core product development functions for over 300 global life sciences companies, today announced that it has been named as a Major Contender in Everest Group’s “Clinical Development Platform Vendors PEAK Matrix Assessment 2020.” The report ranks clinical trial technology providers’ ability to deliver integrated, modular, and interoperable platforms addressing life sciences needs from study start-up to closeout.

ArisGlobal is one of the few Major Contenders identified that provides an end-to-end clinical development platform. The company and others like it are “eating into the Leader’s market share through innovative and digitally mature product launches,” according to the report.

For instance, ArisGlobal’s new LifeSphere® eTMF streamlines the management of trial documentation with a simple cloud solution and the benefits of a unified CTMS.

“We are pleased that Everest Group has named us as a Major Contender on this year’s PEAK Matrix. We have made a deep investment into the rapidly evolving world of clinical technology with a focus on being leaders in innovation and intelligent automation,” said Sankesh Abbhi, President and CEO of ArisGlobal. “It’s amazing to see our efforts paying off with great industry recognition.”

Everest Group pinpointed several ArisGlobal strengths that placed them as a Major Contender, including:

  • Partnerships with CRO’s and helping them increase their scope of coverage to better service their customers
  • Investments to expand the clinical trial value chain coverage or enhance an existing portfolio of solutions
  • ArisGlobal LifeSphere Regulatory platform is cited as an example of portfolio enhancement

The Everest Group PEAK Matrix assesses life sciences companies based on market success and delivery capabilities. Each year, the matrix categories service providers as Leaders, Major Contenders or Aspirants. If a company moves up the ladder in consecutive reports, they are recognized as Star Performers.



About ArisGlobal

ArisGlobal is transforming the way today’s most successful Life Sciences companies develop breakthroughs and bring new products to market. Our end-to-end drug development technology platform, LifeSphere®, integrates our proprietary Nava® cognitive computing engine to automate all core functions of the drug development lifecycle. Designed with deep expertise and a long-term perspective that spans more than 30 years, LifeSphere® is a unified platform that boosts efficiency, ensures compliance, delivers actionable insights, and lowers total cost of ownership through multi-tenant SaaS architecture.

Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China. For more updates, follow ArisGlobal on LinkedIn and Twitter.

Additional Information

Connect with ArisGlobal on LinkedIn:
Follow @Aris_Global on Twitter:


Erika Thomas
+305-726-6601 |